Progentec Diagnostics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Progentec Diagnostics's estimated annual revenue is currently $4M per year.(i)
  • Progentec Diagnostics's estimated revenue per employee is $189,000

Employee Data

  • Progentec Diagnostics has 21 Employees.(i)
  • Progentec Diagnostics grew their employee count by 11% last year.

Progentec Diagnostics's People

NameTitleEmail/Phone
1
Chairman and CEOReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Head AI and Data ScienceReveal Email/Phone
5
High Complexity Clinical Laboratory Director and Clinical ConsultantReveal Email/Phone
6
Senior Manager, OperationsReveal Email/Phone
7
General Counsel and Corporate SecretaryReveal Email/Phone
8
Principal Investigator and ScientistReveal Email/Phone
9
Patient Success CoordinatorReveal Email/Phone
10
Laboratory AccessionerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.8M650%N/AN/A
#2
$60.3M15720%N/AN/A
#3
$13.4M55-10%N/AN/A
#4
$26.5M987%N/AN/A
#5
$31.6M1178%N/AN/A
#6
$364.8M9658%N/AN/A
#7
$13.9M578%N/AN/A
#8
$27.3M10160%N/AN/A
#9
$71.3M24014%N/AN/A
#10
$168.1M4988%N/AN/A
Add Company

What Is Progentec Diagnostics?

Progentec Diagnostics, Inc., was set up to explore and commercialize state of the art diagnostic interventions in therapeutic areas with a high level of unmet need. The company is collaborating with a number of research institutions and individuals around the world engaged in bringing the latest technological innovations to the field of diagnostics. The commitment to this cause is firmly rooted in our belief that better diagnostics would not only help in better and less costly management of diseases, but also help tremendously in reducing the incidence of diseases through early screening and detection.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$4M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Progentec Diagnostics News

2022-04-19 - GlaxoSmithKline PLC - Consensus Indicates Potential 11.2 ...

It has collaboration agreements with 23andMe; Lyell Immunopharma; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics; Alector;...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M21-19%N/A
#2
$3.6M21-5%N/A
#3
$3.3M215%N/A
#4
$3.6M21-5%N/A
#5
$3.1M2222%N/A